Literature DB >> 22369497

Female genital tract shedding of CXCR4-tropic HIV Type 1 is associated with a majority population of CXCR4-tropic HIV Type 1 in blood and declining CD4(+) cell counts.

Richard E Haaland1, Sharon T Sullivan, Tammy Evans-Strickfaden, Jeffrey L Lennox, Clyde E Hart.   

Abstract

This study compared HIV-1 genotypes shed over time (≤3.5 years) in the vaginal secretions (VS) and blood plasma (BP) of 15 chronically infected women. Analysis of predicted coreceptor tropism (CCR5=R5, CXCR4=X4) for quasispecies shedding revealed three patterns: (1) viral quasispecies shed in both VS and BP were restricted to R5-tropism at all time points, (2) quasispecies shed in VS were restricted to R5-tropism at all time points but X4 quasispecies were identified in the BP at one or more time points, and (3) quasispecies shed in matched VS and BP both contained X4-tropic viruses. Overall, the frequency of X4 quasispecies circulation in VS was 2-fold less than in BP and detection of X4 virus in VS was more likely to occur when X4 quasispecies comprised more than 50% of BP viruses (p=0.01) and when declines in blood CD4(+) lymphocyte levels were the greatest (p=0.038). Additionally, the mean number of predicted N-glycosylation sites between matched VS and BP samples was strongly correlated (r=0.86, p<0.0001) with glycosylation densities in the following order (VS R5=BP R5 > BP X4 > VS X4). The X4 glycosylation densities may result from compartmentalization pressures in the female genital tract or the delayed appearance of these viruses in VS. Our results suggest that the presence of X4 virus in VS is associated with a threshold population of X4 quasispecies in BP, which are increasing during the HIV-induced failure of the human immune system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22369497      PMCID: PMC5555632          DOI: 10.1089/AID.2012.0004

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  53 in total

1.  Differences in HIV-1 pol sequences from female genital tract and blood during antiretroviral therapy.

Authors:  Maria Pia De Pasquale; Andrew J Leigh Brown; Susan Cu Uvin; Jessica Allega-Ingersoll; Angela M Caliendo; Lorraine Sutton; Shannon Donahue; Richard T D'Aquila
Journal:  J Acquir Immune Defic Syndr       Date:  2003-09-01       Impact factor: 3.731

2.  Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information.

Authors:  A W Artenstein; T C VanCott; K V Sitz; M L Robb; K F Wagner; S C Veit; A F Rogers; R P Garner; J W Byron; P R Burnett; D L Birx
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

3.  Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy.

Authors:  A J Hance; V Lemiale; J Izopet; D Lecossier; V Joly; P Massip; F Mammano; D Descamps; F Brun-Vézinet; F Clavel
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection.

Authors:  J Mulder; N McKinney; C Christopherson; J Sninsky; L Greenfield; S Kwok
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

Review 5.  The nature and metabolism of the carbohydrate-peptide linkages of glycoproteins.

Authors:  R D Marshall
Journal:  Biochem Soc Symp       Date:  1974

6.  Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1.

Authors:  M Poss; A G Rodrigo; J J Gosink; G H Learn; D de Vange Panteleeff; H L Martin; J Bwayo; J K Kreiss; J Overbaugh
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

7.  Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission.

Authors:  A B van't Wout; N A Kootstra; G A Mulder-Kampinga; N Albrecht-van Lent; H J Scherpbier; J Veenstra; K Boer; R A Coutinho; F Miedema; H Schuitemaker
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

8.  Differential virus evolution in blood and genital tract of HIV-infected females: evidence for the involvement of drug and non-drug resistance-associated mutations.

Authors:  Grissell Tirado; Gloria Jove; Rakesh Kumar; Richard J Noel; Evelyn Reyes; Gladys Sepulveda; Y Yamamura; Anil Kumar
Journal:  Virology       Date:  2004-07-01       Impact factor: 3.616

9.  Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.

Authors:  J Albert; B Abrahamsson; K Nagy; E Aurelius; H Gaines; G Nyström; E M Fenyö
Journal:  AIDS       Date:  1990-02       Impact factor: 4.177

10.  Unselected mutations in the human immunodeficiency virus type 1 genome are mostly nonsynonymous and often deleterious.

Authors:  Feng Gao; Yalu Chen; David N Levy; Joan A Conway; Thomas B Kepler; Huxiong Hui
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

View more
  4 in total

1.  High discordance in blood and genital tract HIV-1 drug resistance in Indian women failing first-line therapy.

Authors:  Shanmugam Saravanan; Selvamurthi Gomathi; Allison Delong; Bagavathi Kausalya; Sathasivam Sivamalar; Selvamuthu Poongulali; Katherine Brooks; Nagalingeswaran Kumarasamy; Pachamuthu Balakrishnan; Sunil S Solomon; Susan Cu-Uvin; Rami Kantor
Journal:  J Antimicrob Chemother       Date:  2018-08-01       Impact factor: 5.790

2.  Human immunodeficiency viruses appear compartmentalized to the female genital tract in cross-sectional analyses but genital lineages do not persist over time.

Authors:  Marta E Bull; Laura M Heath; Jennifer L McKernan-Mullin; Kelli M Kraft; Luis Acevedo; Jane E Hitti; Susan E Cohn; Kenneth A Tapia; Sarah E Holte; Joan A Dragavon; Robert W Coombs; James I Mullins; Lisa M Frenkel
Journal:  J Infect Dis       Date:  2013-01-11       Impact factor: 5.226

Review 3.  So Pathogenic or So What?-A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research.

Authors:  Adam J Kleinman; Ivona Pandrea; Cristian Apetrei
Journal:  Viruses       Date:  2022-01-12       Impact factor: 5.048

4.  Sexually-transmitted/founder HIV-1 cannot be directly predicted from plasma or PBMC-derived viral quasispecies in the transmitting partner.

Authors:  Pierre Frange; Laurence Meyer; Matthieu Jung; Cecile Goujard; David Zucman; Sylvie Abel; Patrick Hochedez; Marine Gousset; Olivier Gascuel; Christine Rouzioux; Marie-Laure Chaix
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.